Connection
Mark Lovell to Brain Chemistry
This is a "connection" page, showing publications Mark Lovell has written about Brain Chemistry.
|
|
Connection Strength |
|
 |
|
 |
|
0.842 |
|
|
|
-
Bradley MA, Markesbery WR, Lovell MA. Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radic Biol Med. 2010 Jun 15; 48(12):1570-6.
Score: 0.332
-
Lovell MA, Smith JL, Xiong S, Markesbery WR. Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease. Neurotox Res. 2005; 7(4):265-71.
Score: 0.232
-
Markesbery WR, Lovell MA. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging. 1998 Jan-Feb; 19(1):33-6.
Score: 0.143
-
Lovell MA, Bradley MA, Fister SX. 4-Hydroxyhexenal (HHE) impairs glutamate transport in astrocyte cultures. J Alzheimers Dis. 2012; 32(1):139-46.
Score: 0.094
-
Rulon LL, Robertson JD, Lovell MA, Deibel MA, Ehmann WD, Markesber WR. Serum zinc levels and Alzheimer's disease. Biol Trace Elem Res. 2000; 75(1-3):79-85.
Score: 0.041